SC1-PHE-CORONAVIRUS-2020
SC1-PHE-CORONAVIRUS-2020
18 projects · €67,755,562 total EU contribution (project-level) · 146 participating organizations · 23 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€67,755,562
Countries active
Participant organizations by country (headquarters in CORDIS).
- Italy (19)
- Germany (17)
- France (17)
- Netherlands (15)
- Spain (12)
- UK (11)
- SE (9)
- BE (8)
- CH (7)
- DK (6)
- CN (5)
- PL (4)
- AT (3)
- FI (2)
- IE (2)
- PT (2)
- AL (1)
- CI (1)
- LT (1)
- NO (1)
- NP (1)
- RO (1)
- US (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- INSERM3 projects · FR
- KI3 projects · SE
- RIVM3 projects · NL
- Leiden University Medical Center2 projects · NL
- ADLEGO BIOMEDICAL AB2 projects · SE
- CSIC2 projects · ES
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2 projects · FR
- ERASMUS MC2 projects · NL
- FOHM2 projects · SE
- HZI2 projects · DE
- IP2 projects · FR
- INMI2 projects · IT
Projects
Page 2 of 2
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Nanobodies and antibodies against 2019-nCoV CoroNAb · 101003653 | H2020 | €2,771,658 | €1,816,859 | Details |
Antibody therapy against coronavirus (COVID-19) ATAC · 101003650 | H2020 | €5,595,040 | €223,545 | Details |
Monoclonal Antibodies against 2019-New Coronavirus MANCO · 101003651 | H2020 | €3,034,581 | €1,614,827 | Details |
COVID-19-Outbreak Response combining E-health, Serolomics, Modelling, Artificial Intelligence and Implementation Research CORESMA · 101003480 | H2020 | €2,759,195 | €1,108,205 | Details |
Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic I-MOVE-COVID-19 · 101003673 | H2020 | €2,808,163 | €0 | Details |
Prevention of SARS-CoV-2 infection through development and clinical testing of a novel Virus Like Particle (VLP) vaccine Prevent-nCoV · 101003608 | H2020 | €2,728,340 | €295,898 | Details |
EXaSCale smArt pLatform Against paThogEns for Corona Virus EXSCALATE4CoV · 101003551 | H2020 | €2,970,875 | €41,250 | Details |
Three Rapid Diagnostic tests (Point-of-Care) for COVID-19 CoronaThree Rapid Diagnostic tests (Point-of-Care) for Coronavirus, improving epidemic preparedness, public health and socio-economic benefits CORONADX · 101003562 | H2020 | €2,970,209 | €296,246 | Details |